Palogic Value Management L.P. Buys New Stake in Amgen Shares
Palogic Value Management L.P. purchased a new stake in Amgen, buying 7,793 shares worth about $2.82 million. Anfield Capital Management and Dogwood Wealth Management also increased holdings, with Anfield owning 77 shares (~$25,000) after adding 70. Other firms raised stakes too, while Sanford C. Bernstein lifted its price target from $335 to $345.